[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 27 of about 27
1. Kim JT, Baek WK, Kim KH, Yoon YH, Kim DH, Lim HK: A primary cardiac sarcoma preoperatively presented as a benign left atrial myxoma. Yonsei Med J; 2003 Jun 30;44(3):530-3
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A primary cardiac sarcoma preoperatively presented as a benign left atrial myxoma.
  • Primary cardiac sarcomas are extremely rare.
  • We report a case of a primary cardiac sarcoma with myxoid change, which originally presented as a benign cardiac myxoma on a two- dimensional echocardiogram.
  • The histological diagnosis was of an undifferentiated primary cardiac sarcoma.
  • The patient had postoperative chemotherapy.
  • The patient expired 11 months after surgery due to a recurrence of the cardiac sarcoma.
  • Although most tumors that develop in the left atrium are benign myxomas, we should make a preoperative differential diagnosis.
  • [MeSH-major] Heart Neoplasms / pathology. Myxoma / pathology. Sarcoma / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Heart Atria. Humans. Intraoperative Period

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12833594.001).
  • [ISSN] 0513-5796
  • [Journal-full-title] Yonsei medical journal
  • [ISO-abbreviation] Yonsei Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  •  go-up   go-down


2. Roh MS, Huh GY, Jeong JS, Lee GD, Hong SH: Left atrial myxosarcoma with systemic metastasis: a case report. J Korean Med Sci; 2001 Feb;16(1):111-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The term myxosarcoma is currently not used in standard classification for soft tissue tumors, but restricted to cardiac tumors.
  • Primary cardiac myxosarcoma is a very rare disease and is difficult to differentiate from myxoma clinically and pathologically.
  • Histologically, the excised tumor showed an amorphous finely fibrillar and mucinous stroma, in which irregular cords and clusters of lepidic cells and large stellate cells with plump vesicular nuclei resembled the usual type of cardiac myxoma were noted.
  • The patient received combination chemotherapy, peripheral blood stem cell collection transplantation and operations for systemic metastases in the brain, skeletal muscle and lung.
  • He is alive at present 37 months after initial diagnosis and has no more new metastatic lesion.
  • [MeSH-major] Heart Neoplasms / pathology. Myxosarcoma / pathology. Myxosarcoma / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11289388.001).
  • [ISSN] 1011-8934
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC3054576
  •  go-up   go-down


3. Ozer N, Deveci OS, Okutucu S, Demircin M: Asymptomatic right atrial myxoma originating from the inferior vena cava and right atrium junction in a patient with breast ductal adenocarcinoma. Turk Kardiyol Dern Ars; 2009 Oct;37(7):479-82
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Asymptomatic right atrial myxoma originating from the inferior vena cava and right atrium junction in a patient with breast ductal adenocarcinoma.
  • We present asymptomatic right atrial myxoma in a patient with breast ductal adenocarcinoma.
  • A 58-year-old female was referred to our clinic for the evaluation of the potential cardiotoxic side effects of anthracycline-based chemotherapy.
  • She had a 10-month history of modified radical mastectomy for ductal adenocarcinoma of the breast, followed by adjuvant chemotherapy.
  • The tumor was completely excised and histopathologic diagnosis was myxoma.
  • Localization of right atrial myxoma at the junction of the inferior vena cava and right atrium is a rare condition, and its coexistence with breast carcinoma has only been reported once.
  • [MeSH-major] Adenocarcinoma / complications. Breast Neoplasms / complications. Carcinoma, Ductal / complications. Heart Atria / pathology. Heart Neoplasms / complications. Myxoma / complications. Vena Cava, Inferior / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20098042.001).
  • [ISSN] 1016-5169
  • [Journal-full-title] Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır
  • [ISO-abbreviation] Turk Kardiyol Dern Ars
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


Advertisement
4. Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni JV: Cardiac tumours in children. Orphanet J Rare Dis; 2007;2:11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cardiac tumours in children.
  • Cardiac tumours are benign or malignant neoplasms arising primarily in the inner lining, muscle layer, or the surrounding pericardium of the heart.
  • Primary cardiac tumours are rare in paediatric practice with a prevalence of 0.0017 to 0.28 in autopsy series.
  • In contrast, the incidence of cardiac tumours during foetal life has been reported to be approximately 0.14%.
  • The vast majority of primary cardiac tumours in children are benign, whilst approximately 10% are malignant.
  • Secondary malignant tumours are 10-20 times more prevalent than primary malignant tumours.
  • Rhabdomyoma is the most common cardiac tumour during foetal life and childhood.
  • It accounts for more than 60% of all primary cardiac tumours.
  • The frequency and type of cardiac tumours in adults differ from those in children with 75% being benign and 25% being malignant.
  • Sarcomas make up 75% of malignant cardiac masses.
  • Echocardiography, Computing Tomography (CT) and Magnetic Resonance Imaging (MRI) of the heart are the main non-invasive diagnostic tools.
  • Cardiac catheterisation is seldom necessary.
  • Tumour biopsy with histological assessment remains the gold standard for confirmation of the diagnosis.
  • Surgical resection of primary cardiac tumours should be considered to relieve symptoms and mechanical obstruction to blood flow.
  • The outcome of surgical resection in symptomatic, non-myxomatous benign cardiac tumours is favourable.
  • Patients with primary cardiac malignancies may benefit from palliative surgery but this approach should not be recommended for patients with metastatic cardiac tumours.
  • Surgery, chemotherapy and radiotherapy may prolong survival.
  • The prognosis for malignant primary cardiac tumours is generally extremely poor.
  • [MeSH-major] Heart Neoplasms / diagnosis. Heart Neoplasms / epidemiology
  • [MeSH-minor] Adult. Age Distribution. Child. Child, Preschool. Female. Fetal Diseases / diagnosis. Fetal Diseases / epidemiology. Fetal Diseases / therapy. Fibroma / diagnosis. Fibroma / epidemiology. Fibroma / therapy. Global Health. Heart Transplantation. Hemangioma / diagnosis. Hemangioma / epidemiology. Hemangioma / therapy. Humans. Infant. Infant, Newborn. Male. Myxoma / diagnosis. Myxoma / epidemiology. Myxoma / therapy. Pregnancy. Prenatal Diagnosis / methods. Prevalence. Rhabdomyoma / diagnosis. Rhabdomyoma / epidemiology. Rhabdomyoma / therapy. Teratoma / diagnosis. Teratoma / epidemiology. Teratoma / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Heart J. 1979 May;97(5):639-43 [433739.001]
  • [Cites] J Med Soc N J. 1979 Mar;76(3):213-5 [286068.001]
  • [Cites] Acta Med Scand. 1979;206(1-2):115-21 [484252.001]
  • [Cites] Pathol Annu. 1979;14 Pt 2:325-55 [232754.001]
  • [Cites] Hum Pathol. 1980 Nov;11(6):598-605 [6778813.001]
  • [Cites] Cancer. 1982 Jan 15;49(2):398-402 [7053836.001]
  • [Cites] J Thorac Cardiovasc Surg. 1982 Mar;83(3):339-48 [7062746.001]
  • [Cites] Hum Pathol. 1993 Nov;24(11):1226-31 [8244322.001]
  • [Cites] Ann Thorac Surg. 1994 Aug;58(2):483-7; discussion 487-8 [8067852.001]
  • [Cites] Am Heart J. 1994 Nov;128(5):1009-21 [7942464.001]
  • [Cites] Ultrasound Obstet Gynecol. 1996 Jan;7(1):84-5 [8932639.001]
  • [Cites] Heart. 1997 Apr;77(4):388 [9155628.001]
  • [Cites] Am J Cardiol. 1997 Sep 1;80(5):671-82 [9295010.001]
  • [Cites] Am Heart J. 1997 Dec;134(6):1107-14 [9424072.001]
  • [Cites] Arch Dis Child. 1998 Feb;78(2):159-62 [9579160.001]
  • [Cites] Ann Thorac Surg. 1998 May;65(5):1388-90 [9594871.001]
  • [Cites] J Child Neurol. 1998 Dec;13(12):624-8 [9881533.001]
  • [Cites] Cancer. 1999 Jan 1;85(1):78-84 [9921977.001]
  • [Cites] Ultrasound Obstet Gynecol. 1999 May;13(5):363-5 [10380304.001]
  • [Cites] Circulation. 1962 Aug;26:228-41 [14037856.001]
  • [Cites] Chest. 1982 Apr;81(4):511-2 [7067518.001]
  • [Cites] J Am Coll Cardiol. 1984 Mar;3(3):827-32 [6693654.001]
  • [Cites] J Am Coll Cardiol. 1984 Mar;3(3):868-71 [6693658.001]
  • [Cites] J Thorac Cardiovasc Surg. 1984 May;87(5):725-31 [6717050.001]
  • [Cites] Cancer. 1985 Aug 15;56(4):825-36 [4016674.001]
  • [Cites] Mayo Clin Proc. 1986 Mar;61(3):165-72 [3945116.001]
  • [Cites] Circulation. 1987 Apr;75(4):705-10 [3829332.001]
  • [Cites] J Thorac Cardiovasc Surg. 1987 Apr;93(4):502-11 [3560997.001]
  • [Cites] Am Heart J. 1987 Oct;114(4 Pt 1):782-92 [3310564.001]
  • [Cites] Hum Pathol. 1988 Nov;19(11):1361-2 [3181957.001]
  • [Cites] Am J Cardiol. 1989 Apr 15;63(13):1006-8 [2929455.001]
  • [Cites] Am J Pediatr Hematol Oncol. 1989 Fall;11(3):343-7 [2782566.001]
  • [Cites] Ann Thorac Surg. 1990 Apr;49(4):612-7; discussion 617-8 [2322057.001]
  • [Cites] Ann Thorac Surg. 1990 Oct;50(4):557-61 [2222043.001]
  • [Cites] Am J Cardiol. 1990 Nov 15;66(17):1247-9 [2239731.001]
  • [Cites] Am J Med Genet. 1990 Dec;37(4):443-6 [2260584.001]
  • [Cites] Ann N Y Acad Sci. 1991;615:50-7 [2039167.001]
  • [Cites] Am J Cardiovasc Pathol. 1990;3(3):195-8 [2095826.001]
  • [Cites] Am J Cardiovasc Pathol. 1990;3(4):283-90 [2129569.001]
  • [Cites] Am J Cardiol. 1992 Jan 15;69(3):283-5 [1731477.001]
  • [Cites] J Thorac Cardiovasc Surg. 1992 Apr;103(4):655-64 [1548908.001]
  • [Cites] Obstet Gynecol. 1992 May;79(5 ( Pt 2)):856-9 [1565387.001]
  • [Cites] Am J Cardiovasc Pathol. 1992;4(1):85-90 [1627332.001]
  • [Cites] Arch Mal Coeur Vaiss. 1992 May;85(5):603-8 [1530401.001]
  • [Cites] Cancer. 1992 Oct 15;70(8):2203-7 [1394052.001]
  • [Cites] Arch Dis Child. 1992 Oct;67(10 Spec No):1189-92 [1444556.001]
  • [Cites] Arch Dis Child. 1993 Mar;68(3):367-70 [8466239.001]
  • [Cites] Arch Pathol Lab Med. 1993 Oct;117(10):1027-31 [8215825.001]
  • [Cites] Tex Heart Inst J. 1993;20(3):231-4 [8219827.001]
  • [Cites] Pediatr Radiol. 1993;23(5):384-5 [8233695.001]
  • [Cites] J Paediatr Child Health. 2000 Feb;36(1):84-6 [10723700.001]
  • [Cites] J Thorac Cardiovasc Surg. 1994 Nov;108(5):862-70 [7967668.001]
  • [Cites] Pediatr Pathol. 1994 Nov-Dec;14(6):913-7 [7855010.001]
  • [Cites] Am J Med Genet. 1994 Nov 1;53(2):141-8 [7856638.001]
  • [Cites] Ann Surg. 1995 Apr;221(4):415-9 [7726678.001]
  • [Cites] J Am Coll Cardiol. 1995 Aug;26(2):516-20 [7608458.001]
  • [Cites] Am J Cardiol. 1995 Aug 15;76(5):419-21 [7639176.001]
  • [Cites] N Engl J Med. 1995 Dec 14;333(24):1610-7 [7477198.001]
  • [Cites] Ann Thorac Surg. 1996 Aug;62(2):559-64 [8694623.001]
  • [Cites] Heart. 1996 Aug;76(2):188 [8795490.001]
  • [Cites] Acta Paediatr. 1996 Aug;85(8):928-31 [8863873.001]
  • [Cites] Cardiovasc Pathol. 2000 Jan-Feb;9(1):55-7 [10739909.001]
  • [Cites] Pediatr Cardiol. 2000 Jul-Aug;21(4):317-23 [10865004.001]
  • [Cites] Heart. 2001 Feb;85(2):218-22 [11156679.001]
  • [Cites] Pathology. 2001 May;33(2):230-4 [11358060.001]
  • [Cites] Cell Signal. 2003 Aug;15(8):729-39 [12781866.001]
  • [Cites] Pediatr Cardiol. 2004 May-Jun;25(3):252-73 [15360117.001]
  • [Cites] Circulation. 1967 Sep;36(3):427-40 [6033170.001]
  • [Cites] Am J Cardiol. 1968 Mar;21(3):363-6 [4866645.001]
  • [Cites] Am J Cardiol. 1968 Jul;22(1):85-107 [4873149.001]
  • [Cites] Arch Dis Child. 1971 Aug;46(248):508-14 [5565462.001]
  • [Cites] Arch Pathol. 1973 Jan;95(1):26-36 [4682025.001]
  • [Cites] Eur J Cardiol. 1975 Jun;3(1):71-3 [1132411.001]
  • [Cites] Am J Cardiol. 1976 Aug;38(2):241-51 [952267.001]
  • (PMID = 17331235.001).
  • [ISSN] 1750-1172
  • [Journal-full-title] Orphanet journal of rare diseases
  • [ISO-abbreviation] Orphanet J Rare Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 78
  • [Other-IDs] NLM/ PMC3225855
  •  go-up   go-down


5. Karpuz V, Ikitimur B, Karpuz H: [A survey of heart tumors: clinical and echocardiographic approach]. Anadolu Kardiyol Derg; 2007 Dec;7(4):427-35

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A survey of heart tumors: clinical and echocardiographic approach].
  • Heart tumors can be primary in origin, can develop from direct extension of a neighboring tumor or they can be the manifestation of metastasis of a distant tumor.
  • Myxomas are the most frequently encountered primary benign cardiac tumors.
  • Primary malignant tumors of the heart are rare, and they are mostly sarcomatous in structure.
  • Secondary heart tumors constitute a wide spectrum, nevertheless they most frequently originate from lung cancer, breast cancer and hematological malignancies.
  • Heart tumors may involve myocardium, endocardium, epicardium, pericardium, or any combination of the aforementioned layers.
  • On the other hand, the usual site for metastasis to the heart is the pericardium.
  • Magnetic resonance imaging and computerized tomography may be helpful for selected cases.
  • Surgery is the principal therapeutic option in benign tumors and when recurrences are not taken into account, they have favorable prognoses.
  • Since surgical resection is usually incomplete in malignant tumors, therapy must be individualized for each patient; even with adjuvant chemotherapy, postoperative survival is usually short.
  • Metastases to the heart are usually approached symptomatically except for exceptional cases.
  • [MeSH-major] Heart Neoplasms / diagnosis
  • [MeSH-minor] Echocardiography, Transesophageal. Fibroma / diagnosis. Fibroma / pathology. Fibroma / radiography. Fibroma / ultrasonography. Hemangioma / diagnosis. Hemangioma / pathology. Hemangioma / radiography. Hemangioma / ultrasonography. Humans. Magnetic Resonance Imaging. Myoma / diagnosis. Myoma / pathology. Myoma / radiography. Myoma / ultrasonography. Myxoma / diagnosis. Myxoma / pathology. Myxoma / radiography. Myxoma / ultrasonography. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18065342.001).
  • [ISSN] 1308-0032
  • [Journal-full-title] Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
  • [ISO-abbreviation] Anadolu Kardiyol Derg
  • [Language] tur
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Turkey
  • [Number-of-references] 49
  •  go-up   go-down


6. Aksu T, Güler ET, Tüfekçioğlu O, Aksu AO: [Thrombi in the right atrium and inferior vena cava mimicking myxoma in a patient with recurrent pulmonary thromboembolism]. Turk Kardiyol Dern Ars; 2008 Dec;36(8):555-7
MedlinePlus Health Information. consumer health - Deep Vein Thrombosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Thrombi in the right atrium and inferior vena cava mimicking myxoma in a patient with recurrent pulmonary thromboembolism].
  • A 26-year-old male patient presented with complaints of pain, dyspnea, and hemoptysis of one-week history, while on oral anticoagulation treatment that had been started two years before upon the diagnosis of pulmonary thromboembolism.
  • The possibility of vegetation or secondary cardiac tumor was excluded by further examinations and, considering consistent oral anticoagulation, no other cause could be determined related to thrombus formation.
  • Multiple cardiac myxomas were thought for the differential diagnosis and the patient underwent surgery.
  • Histopathologic diagnosis of both masses was thrombus.
  • [MeSH-major] Fibrinolytic Agents / therapeutic use. Heart Atria / ultrasonography. Vena Cava, Inferior / ultrasonography. Venous Thrombosis / ultrasonography
  • [MeSH-minor] Adult. Diagnosis, Differential. Heart Neoplasms / diagnosis. Heart Neoplasms / ultrasonography. Humans. Male. Myxoma / diagnosis. Myxoma / ultrasonography. Pulmonary Embolism / diagnosis. Pulmonary Embolism / drug therapy. Pulmonary Embolism / ultrasonography. Recurrence

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19223724.001).
  • [ISSN] 1016-5169
  • [Journal-full-title] Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır
  • [ISO-abbreviation] Turk Kardiyol Dern Ars
  • [Language] tur
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Turkey
  • [Chemical-registry-number] 0 / Fibrinolytic Agents
  •  go-up   go-down


7. Ibrahim M, Iliescu C, Safi HJ, Buja ML, McPherson DD, Fuentes F: Biatrial myxoma and cerebral ischemia successfully treated with intravenous thrombolytic therapy and surgical resection. Tex Heart Inst J; 2008;35(2):193-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biatrial myxoma and cerebral ischemia successfully treated with intravenous thrombolytic therapy and surgical resection.
  • We report what we believe is the 1st case in the medical literature in which an intravenous thrombolytic agent was used successfully--without massive intracranial bleeding--to treat acute stroke induced by atrial myxoma.
  • Transesophageal echocardiography was essential in clarifying the diagnosis and in helping to direct surgical treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 1980 Oct;101(1):219-40 [7446701.001]
  • [Cites] Ann Thorac Surg. 2003 Dec;76(6):1935-8 [14667616.001]
  • [Cites] Thorac Cardiovasc Surg. 1990 Aug;38 Suppl 2:183-91 [2237900.001]
  • [Cites] Mayo Clin Proc. 1992 Oct;67(10):957-65 [1434856.001]
  • [Cites] N Engl J Med. 1995 Dec 14;333(24):1610-7 [7477198.001]
  • [Cites] Int J Cardiol. 2005 May 11;101(1):115-21 [15860393.001]
  • [Cites] Acta Cardiol. 2006 Jun;61(3):285-8 [16869448.001]
  • [Cites] Int J Cardiol. 2006 Nov 18;113(3):E76-8 [16757045.001]
  • [Cites] Am J Forensic Med Pathol. 1996 Dec;17(4):271-81 [8947350.001]
  • [Cites] Ann Thorac Surg. 1997 Mar;63(3):697-700 [9066386.001]
  • [Cites] Neurology. 1997 Aug;49(2):618-20 [9270611.001]
  • [Cites] No Shinkei Geka. 2000 Jul;28(7):653-8 [10920828.001]
  • [Cites] Jpn Circ J. 2001 Apr;65(4):315-9 [11316130.001]
  • [Cites] Medicine (Baltimore). 2001 May;80(3):159-72 [11388092.001]
  • [Cites] Eur J Cardiothorac Surg. 2002 Dec;22(6):971-7 [12467822.001]
  • [Cites] Cardiovasc Pathol. 2003 Sep-Oct;12(5):267-70 [14507576.001]
  • [Cites] J Thorac Cardiovasc Surg. 1982 Mar;83(3):339-48 [7062746.001]
  • (PMID = 18612442.001).
  • [ISSN] 0730-2347
  • [Journal-full-title] Texas Heart Institute journal
  • [ISO-abbreviation] Tex Heart Inst J
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fibrinolytic Agents; EC 3.4.21.68 / Tissue Plasminogen Activator
  • [Other-IDs] NLM/ PMC2435448
  • [Keywords] NOTNLM ; Cerebrovascular accident / echocardiography, transesophageal / embolism / heart atria/surgery / heart neoplasms/complications/diagnosis/surgery / intracranial embolism and thrombosis/etiology/drug therapy / myxoma / thrombolytic therapy / tissue plasminogen activator
  •  go-up   go-down


8. Kaynak K, Beşirli K, Arslan C, Ozgüroğlu M, Oz B: Metastatic cardiac myxoma. Ann Thorac Surg; 2001 Aug;72(2):623-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic cardiac myxoma.
  • A 22-year-old woman who had a history of three cardiac operations and a bilateral femoral embolectomy for recurrent cardiac myxoma and myxoma embolism, respectively, was accepted to our clinic with multiple immobile peripheral masses.
  • Pathology examination revealed myxoma.
  • Chemotherapy was given to the patient and regression of the masses was observed.
  • [MeSH-major] Heart Neoplasms / surgery. Myxoma / surgery. Neoplasm Recurrence, Local / surgery. Soft Tissue Neoplasms / secondary
  • [MeSH-minor] Adult. Female. Femoral Nerve / pathology. Femoral Nerve / surgery. Femoral Neuropathy / pathology. Femoral Neuropathy / surgery. Follow-Up Studies. Heart Atria / pathology. Heart Atria / surgery. Heart Ventricles / pathology. Heart Ventricles / surgery. Humans. Neoplastic Cells, Circulating. Nerve Compression Syndromes / pathology. Nerve Compression Syndromes / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11515919.001).
  • [ISSN] 0003-4975
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Hill G, Castellino S, Williams D: Cardiac myxoma after treatment for childhood neuroblastoma. Pediatr Cardiol; 2009 Apr;30(3):340-2
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cardiac myxoma after treatment for childhood neuroblastoma.
  • An asymptomatic 13 year old with a history of neuroblastoma treated with chemotherapy, radiation therapy, and autologous bone marrow transplant was found to have a cardiac mass on screening echocardiogram.
  • Surgical resection and histologic examination revealed the mass was a myxoma.
  • This report reviews the features of myxoma and explores the potential relationship between chemotherapy, radiation, bone marrow transplant and myxoma.
  • [MeSH-major] Adrenal Gland Neoplasms / therapy. Heart Neoplasms / etiology. Myxoma / etiology. Neuroblastoma / therapy
  • [MeSH-minor] Adolescent. Cardiac Surgical Procedures. Diagnosis, Differential. Echocardiography. Follow-Up Studies. Humans. Male. Risk Factors. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Heart J. 1986 Apr;111(4):803-5 [3953410.001]
  • [Cites] N Engl J Med. 1983 Mar 10;308(10):588 [6828083.001]
  • [Cites] Hum Pathol. 1993 Sep;24(9):1008-11 [8253455.001]
  • [Cites] Acta Cardiol. 2006 Jun;61(3):285-8 [16869448.001]
  • [Cites] N Engl J Med. 2006 Oct 12;355(15):1572-82 [17035650.001]
  • [Cites] Bone Marrow Transplant. 1998 Apr;21(8):825-7 [9603408.001]
  • [Cites] Am J Cardiol. 1984 Jan 15;53(2):379-80 [6695754.001]
  • [Cites] Am J Cardiol. 1987 Jan 1;59(1):182-3 [3812241.001]
  • [Cites] Lancet Oncol. 2005 Apr;6(4):219-28 [15811617.001]
  • [Cites] Am J Pathol. 1980 Oct;101(1):219-40 [7446701.001]
  • [Cites] Pathol Annu. 1979;14 Pt 2:325-55 [232754.001]
  • [Cites] Orphanet J Rare Dis. 2007 Mar 01;2:11 [17331235.001]
  • (PMID = 18716707.001).
  • [ISSN] 1432-1971
  • [Journal-full-title] Pediatric cardiology
  • [ISO-abbreviation] Pediatr Cardiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Barh D, Kumar A, Chatterjee S, Liloglou T: Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma. Curr Cancer Drug Targets; 2009 Sep;9(6):705-16

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma.
  • Treatment of sporadic cardiac myxoma (CM) has always been a challenging task.
  • Currently, surgical excision remains the only option; however, targeted drug discovery schemes are in progress in order to improve treatment strategies and efficacy.
  • The molecular mechanisms behind CM pathogenesis are still not totally unveiled thus drug target identification is still at early steps, trying to compile structured data on the pathophysiology of CM, targets and targeting moieties.
  • In addition, 15 to 20 drug targets and their targeting molecules have also mapped on pathways in an effort to start decoding the molecular profiles based on which early efforts for CM patient stratification into targeted therapeutic regimes.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Drug Delivery Systems. Heart Neoplasms / drug therapy. Heart Neoplasms / metabolism. Myxoma / drug therapy. Myxoma / metabolism. Signal Transduction / drug effects
  • [MeSH-minor] Antineoplastic Agents / pharmacology. Antineoplastic Agents / therapeutic use. Cell Line. Drug Discovery. Humans. Models, Biological. Mutation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19754355.001).
  • [ISSN] 1873-5576
  • [Journal-full-title] Current cancer drug targets
  • [ISO-abbreviation] Curr Cancer Drug Targets
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor
  • [Number-of-references] 165
  •  go-up   go-down


11. Yamanome T, Yoshida K, Miura K, Ogawa A: [Superselective fibrinolysis for a middle cerebral artery embolism caused by a left atrial myxoma: case report]. No Shinkei Geka; 2000 Jul;28(7):653-8
Genetic Alliance. consumer health - Embolism.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Superselective fibrinolysis for a middle cerebral artery embolism caused by a left atrial myxoma: case report].
  • A case of successful treatment by local fibrinolysis of a middle cerebral artery embolism caused by a thrombus from a left atrial myxoma is reported.
  • Local fibrinolysis using a tissue plasminogen activator was performed within 3 hours after the beginning of the episode, and partial recanalization was obtained within one hour after initiation of the fibrinolytic therapy.
  • Considering the possibility of a cardiac source of the embolism, trans-esophageal echocardiography was performed and revealed a left atrial tumor suspected to be a myxoma.
  • Histological examination proved it to be a myxoma.
  • Nine months after local fibrinolytic therapy, the patient returned to work.
  • The diagnosis of cerebral embolism caused by cardiac myxoma is difficult to make at the time when the patient is first examined after admission.
  • It is also hard to discover during emergent cerebral angiography with fibrinolytic therapy.
  • Therefore, in the case of patients with cerebral embolism for which local fibrinolysis is ineffective, it should be presumed that cardiac myxoma is the source of the embolus.
  • [MeSH-major] Heart Neoplasms / complications. Intracranial Embolism / drug therapy. Myxoma / complications. Thrombolytic Therapy / methods
  • [MeSH-minor] Female. Fibrinolytic Agents / administration & dosage. Heart Atria. Humans. Middle Aged. Tissue Plasminogen Activator / administration & dosage. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10920828.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] JAPAN
  • [Chemical-registry-number] 0 / Fibrinolytic Agents; EC 3.4.21.68 / Tissue Plasminogen Activator
  • [Number-of-references] 23
  •  go-up   go-down


12. Sarjeant JM, Butany J, Cusimano RJ: Cancer of the heart: epidemiology and management of primary tumors and metastases. Am J Cardiovasc Drugs; 2003;3(6):407-21
HIV InSite. treatment guidelines - Human Herpesvirus-8 .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cancer of the heart: epidemiology and management of primary tumors and metastases.
  • Cardiac tumors, benign or malignant, are rare and most are benign.
  • The most common benign tumor is the cardiac myxoma.
  • Malignant cardiac tumors are usually sarcomas.
  • The pericardium can be the site of benign and malignant cardiac tumors, though metastatic tumors occur here far more commonly than do primary tumors.
  • Successful treatment for benign cardiac tumors is usually achieved by surgical resection.
  • Primary cardiac lymphoma may be successfully treated by chemotherapy.
  • Tumors that metastasize to the heart from other organs occur 100- to 1000-fold more commonly than primary cardiac tumors.
  • Metastatic spread to the heart has been identified in approximately one-fifth of all patients who have metastatic cancer with lung carcinoma being the most common primary tumor.
  • Symptoms of cardiac metastases vary, and they depend on the site and extent of the lesions.
  • Treatment varies depending on the pathology of the primary tumor.
  • However, the aim of treatment is usually symptomatic relief.
  • With the advent of AIDS, Kaposi's sarcoma and high grade B cell lymphomas have also been identified in cardiac tissue.
  • The aim of this article is to review the epidemiology, clinical presentation, pathology and treatment of cardiac tumors.
  • [MeSH-major] Heart Neoplasms
  • [MeSH-minor] Acquired Immunodeficiency Syndrome / complications. Carcinoid Heart Disease / diagnosis. Carcinoid Heart Disease / pathology. Hematologic Neoplasms / diagnosis. Hematologic Neoplasms / pathology. Humans. Neoplasm Metastasis. Pericardium / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14728061.001).
  • [ISSN] 1175-3277
  • [Journal-full-title] American journal of cardiovascular drugs : drugs, devices, and other interventions
  • [ISO-abbreviation] Am J Cardiovasc Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] New Zealand
  • [Number-of-references] 62
  •  go-up   go-down


13. Ariki H, Mizuno S, Tsunekawa T, Doi T: [Left atrial sarcoma with the initial diagnosis of myxoma]. Kyobu Geka; 2005 Jun;58(6):462-5
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Left atrial sarcoma with the initial diagnosis of myxoma].
  • Primary tumors of the heart are rare.
  • Almost all malignant tumors are sarcomas and occur preferentially in the right side of the heart.
  • Echocardiography revealed a left atrial mass that was interpreted as atrial myxoma.
  • The patient survived the operation without adjuvant radiation and chemotherapy and has been symptom-free over 1 year.
  • [MeSH-major] Heart Neoplasms / diagnosis. Myxoma / diagnosis. Sarcoma / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Heart Atria. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15957419.001).
  • [ISSN] 0021-5252
  • [Journal-full-title] Kyobu geka. The Japanese journal of thoracic surgery
  • [ISO-abbreviation] Kyobu Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


14. Karachalios G, Bablekos G, Karachaliou I, Zoganas L, Charalabopoulos A, Charalabopoulos K: Left atrial myxoma prolapsing into the left ventricle. Case report and review of the literature. Chemotherapy; 2004 Dec;50(6):297-301
Hazardous Substances Data Bank. CLOXACILLIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Left atrial myxoma prolapsing into the left ventricle. Case report and review of the literature.
  • Cardiac myxomas are rare tumors which may present differently.
  • Left atrial myxoma is an entity from anatomopathological and clinical aspects.
  • Herein, we present a patient with a left atrial myxoma prolapsing into the left ventricle in the diastolic phase, which was infected with Streptococcus viridans.
  • Combined therapy, consisting of surgical management and antimicrobial therapy, was used.
  • Clinical presentation, diagnosis and treatment are reviewed.
  • [MeSH-major] Heart Neoplasms / diagnosis. Heart Neoplasms / therapy. Myxoma / diagnosis. Myxoma / therapy. Streptococcal Infections / diagnosis. Streptococcal Infections / drug therapy. Viridans Streptococci / isolation & purification
  • [MeSH-minor] Anti-Bacterial Agents / therapeutic use. Ceftazidime / therapeutic use. Cephalosporins / therapeutic use. Cloxacillin / therapeutic use. Combined Modality Therapy. Diagnosis, Differential. Echocardiography, Transesophageal / methods. Gentamicins / therapeutic use. Heart Atria / pathology. Heart Atria / surgery. Heart Atria / ultrasonography. Heart Ventricles / pathology. Heart Ventricles / ultrasonography. Humans. Male. Middle Aged. Netilmicin / therapeutic use. Teicoplanin / therapeutic use. Treatment Outcome. Vancomycin / therapeutic use

  • MedlinePlus Health Information. consumer health - Streptococcal Infections.
  • Hazardous Substances Data Bank. Vancomycin .
  • Hazardous Substances Data Bank. NETILMICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2004 S. Karger AG, Basel.
  • (PMID = 15608446.001).
  • [ISSN] 0009-3157
  • [Journal-full-title] Chemotherapy
  • [ISO-abbreviation] Chemotherapy
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Cephalosporins; 0 / Gentamicins; 4O5J85GJJB / Netilmicin; 61036-62-2 / Teicoplanin; 6Q205EH1VU / Vancomycin; 807PW4VQE3 / cefepime; 9M416Z9QNR / Ceftazidime; O6X5QGC2VB / Cloxacillin
  •  go-up   go-down


15. Yu L, Gu TX, Shi EY, Xiu ZY, Fang Q: [Diagnosis and therapy of primary malignant tumors of the heart and pericardium]. Zhonghua Zhong Liu Za Zhi; 2009 Mar;31(3):230-2
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis and therapy of primary malignant tumors of the heart and pericardium].
  • OBJECTIVE: To summarize and analyze the experience in diagnosis and treatment of primary malignant tumors of the heart and pericardium.
  • METHODS: The clinical data of 24 patients with malignant tumors of the heart and pericardium treated in our hospital between Jun.
  • RESULTS: All 24 patients received surgical treatment.
  • CONCLUSION: Echocardiography, CT, MRI, 3D-CT, CT of coronary artery and cardiac angiography are helpful for the diagnosis and selection of operation mode.
  • Histological examination is necessary for the final diagnosis.
  • Early diagnosis and surgical resection of the tumor as complete as possible, and combination with post-operative radiotherapy and/or chemotherapy may improve the survival of the patients.
  • [MeSH-major] Heart Neoplasms / diagnosis. Heart Neoplasms / surgery. Mesothelioma / diagnosis. Mesothelioma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Myxoma / diagnosis. Myxoma / surgery. Pericardium / surgery. Retrospective Studies. Survival Rate. Young Adult

  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19615268.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


16. Canadyova J, Setina M, Smetanová S, Mokracek A: Leiomyosarcoma of the left atrium. Asian Cardiovasc Thorac Ann; 2008 Jan;16(1):e7-9
Hazardous Substances Data Bank. IFOSFAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The preferential left atrial location and frequent myxoid appearance of leiomyosarcoma of the heart make it particularly difficult to distinguish preoperatively from atrial myxoma.
  • Early diagnosis and aggressive surgical intervention with chemotherapy may improve the prognosis.
  • [MeSH-major] Heart Neoplasms / diagnosis. Leiomyosarcoma / diagnosis. Myxoma / diagnosis
  • [MeSH-minor] Adult. Antineoplastic Agents, Alkylating / therapeutic use. Cardiac Surgical Procedures. Chemotherapy, Adjuvant. Diagnosis, Differential. Echocardiography, Transesophageal. Female. Heart Atria / pathology. Humans. Ifosfamide / therapeutic use. Positron-Emission Tomography

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18245694.001).
  • [ISSN] 1816-5370
  • [Journal-full-title] Asian cardiovascular & thoracic annals
  • [ISO-abbreviation] Asian Cardiovasc Thorac Ann
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


17. Durrleman N, El Hamamsy I, Demaria R, Carrier M, Perrault LP, Albat B: [Is Dacron carcinogenic? Apropos of a case and review of the literature]. Arch Mal Coeur Vaiss; 2004 Mar;97(3):267-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary malignant cardiac tumours are extremely rare.
  • The authors report a case of primary cardiac lymphoma nine years after implantation of a double leaflet mitral valve prosthesis.
  • It typically presents as a nodular or diffuse myocardial infiltrate explaining its clinical expression as cardiac failure and atrioventricular block.
  • Survival after "pure" medical therapy (chemotherapy alone or associated with radiotherapy) is 6 to 8 months after diagnosis.
  • Dacron has been implicated in the pathogenesis of primary cardiac sarcoma.
  • In conclusion, although primary cardiac lymphoma is a rare condition, it should be considered, as with thrombosis, a possible differential diagnosis of acute dysfunction of cardiac valvular prostheses.
  • [MeSH-major] Heart Neoplasms / etiology. Heart Valve Prosthesis / adverse effects. Lymphoma, Large-Cell, Immunoblastic / etiology. Polyethylene Terephthalates / adverse effects
  • [MeSH-minor] Abdominal Neoplasms / drug therapy. Abdominal Neoplasms / secondary. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Asthenia / etiology. Diagnostic Errors. Fatal Outcome. Female. Humans. Mitral Valve / surgery. Multiple Organ Failure / etiology. Myxoma / diagnosis. Sarcoma / chemically induced. Thrombosis / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15106752.001).
  • [ISSN] 0003-9683
  • [Journal-full-title] Archives des maladies du coeur et des vaisseaux
  • [ISO-abbreviation] Arch Mal Coeur Vaiss
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Polyethylene Terephthalates
  • [Number-of-references] 10
  •  go-up   go-down


18. Milicic D, Juretic A, Bulum J, Saric N, Bisof V, Jelic I, Jelasic D: Primary malignant fibrous histiocytoma of the heart with skeletal muscles metastases. J Card Surg; 2007 Nov-Dec;22(6):513-6
Genetic Alliance. consumer health - Malignant fibrous histiocytoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary malignant fibrous histiocytoma of the heart with skeletal muscles metastases.
  • Malignant fibrous histiocytoma is an extremely rare primary malignant tumor of the heart.
  • The prognosis is poor with an average survival time of one year.
  • We report a case of recurrent left atrial malignant fibrous histiocytoma initially misdiagnosed as myxoma.
  • The patient underwent repeated surgical resections followed by chemotherapy.
  • Despite adjuvant chemotherapy, 18 months after initial diagnosis, definitive tumor relapse in left atrium was diagnosed.
  • This is the 48th case of primary cardiac fibrous malignant histiocytoma reported in the literature.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / diagnosis. Muscle Neoplasms / diagnosis. Muscle, Skeletal / pathology
  • [MeSH-minor] Female. Heart Neoplasms / pathology. Humans. Middle Aged. Prognosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18039217.001).
  • [ISSN] 0886-0440
  • [Journal-full-title] Journal of cardiac surgery
  • [ISO-abbreviation] J Card Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


19. Pirkova AA, Samoĭlova EV, Ameliushkina VA, Kaminnyĭ AI, Titov VN, Prokazova NV, Naumov VG, Kucharchuk VV, Korotaeva AA: [Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease]. Kardiologiia; 2007;47(4):37-40
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease].
  • We studied effect of atorvastatin on secretory phospholipase A2 group IIA (sPLA2-IIA) in blood serum of patients with ischemic heart disease (IHD), lipid composition of low density lipoproteins (LDL) and process of modification of LDL induced by sPLA2-IIA in 20 patients taking 20 mg/day of atorvastatin for 3 months.
  • At incubation of LDL, extracted from patient s plasma before initiation of the study, with human sPLA2-IIA from cardiac myxoma, 3.5 nmol of lysolecithin per 1 mg of LDL protein was formed while at incubation of LDL of same patients, extracted after 3 months of atorvastatin administration, amount of lysolecithin was 1.54 nmol/mg LDL protein.
  • Thus atorvastatin therapy causes lowering of sPLA2-IIA in patients with initially high blood level of the enzyme and to a great extent precludes sPLA2-IIA induced LDL modification.
  • [MeSH-major] Anticholesteremic Agents / therapeutic use. Group II Phospholipases A2 / blood. Heptanoic Acids / therapeutic use. Lipoproteins, LDL / blood. Myocardial Ischemia / blood. Myocardial Ischemia / drug therapy. Pyrroles / therapeutic use
  • [MeSH-minor] Aged. Atorvastatin Calcium. Cholesterol / blood. Humans. Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use. Lecithins / blood. Lysophosphatidylcholines / blood. Male. Middle Aged. Treatment Outcome. Triglycerides / blood

  • Genetic Alliance. consumer health - Heart Disease.
  • Hazardous Substances Data Bank. CHOLESTEROL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18260836.001).
  • [ISSN] 0022-9040
  • [Journal-full-title] Kardiologiia
  • [ISO-abbreviation] Kardiologiia
  • [Language] rus
  • [Publication-type] Clinical Trial; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Anticholesteremic Agents; 0 / Heptanoic Acids; 0 / Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0 / Lecithins; 0 / Lipoproteins, LDL; 0 / Lysophosphatidylcholines; 0 / Pyrroles; 0 / Triglycerides; 48A5M73Z4Q / Atorvastatin Calcium; 97C5T2UQ7J / Cholesterol; EC 3.1.1.4 / Group II Phospholipases A2; EC 3.1.1.4 / PLA2G2A protein, human
  •  go-up   go-down


20. Kisselbach C, Ristic AD, Pankuweit S, Karatolius K, Maisch B: [Women and pericardial neoplastic manifestations of the heart and pericardium]. Herz; 2005 Aug;30(5):409-15; quiz 429-30
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Women and pericardial neoplastic manifestations of the heart and pericardium].
  • In the Western world more than 450,000 women succumb to heart disease annually.
  • Despite the proportions, most women believe that heart disease is a man's disease and that they will die of breast cancer.
  • Data on epidemiology and incidence are rare: there is only an estimated incidence of cardiac neoplasm at necropsy ranging from 0,001% to 0,3%.
  • The most common tumor entity is benign cardiac myxoma.
  • Malignant heart tumors are less common.
  • Most often they are different types of sarcomas, which have a poor outcome and affect more males than females.
  • Metastatic tumors of the heart are 100 times more common than the primary ones.
  • To prevent death from tamponade, pericardiocentesis, in addition to the systemic chemotherapy, is mandatory, best when instillation of chemotherapeutics (cisplatin or thiotepa) or radioisotopes is given into the pericardial sac to prevent recurrence of the effusion.
  • METHODS: A retrospective study was conducted of all patients with cardiac and pericardial neoplasm exactly diagnosed by endomyocardial or epicardial biopsy and pericardiocentesis, using hospital medical records and a biopsy and pericardiocentesis registry from 2000-2005 with 297 patients.
  • CONCLUSION: Females are more often affected by primary cardiac tumors than males with an excellent outcome.
  • By contrast, the preventive checkup and aftercare will gain more prognostic importance, especially in case of breast cancer, to earlier recognize a secondary cardiac neoplasm by biopsy and pericardiocentesis with intrapericardial treatment of neoplastic pericarditis.
  • [MeSH-major] Breast Neoplasms / epidemiology. Breast Neoplasms / secondary. Heart Neoplasms / epidemiology. Heart Neoplasms / secondary. Lung Neoplasms / epidemiology. Lung Neoplasms / secondary. Registries. Risk Assessment / methods

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16132244.001).
  • [ISSN] 0340-9937
  • [Journal-full-title] Herz
  • [ISO-abbreviation] Herz
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


21. Riberi A, Gariboldi V, Grisoli D, Collart F: [Cardiac tumors]. Rev Pneumol Clin; 2010 Feb;66(1):95-103

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cardiac tumors].
  • Primary cardiac tumor is a rare disease, with an incidence ranging from 0.001 to 0.03%.
  • Primary malignant tumors of heart are in 95% of cases sarcomas, the remaining 5% are lymphomas.
  • Cardiac's metastases are more frequent than primary tumors.
  • Diagnosis is made by echocardiography TAC and MRI.
  • Whereas surgery is indicated in patients with benign tumors, or localised sarcomas, chemotherapy in those with widespread disease and radiotherapy and chemotherapy in lymphoma.
  • Prognosis is excellent in benign cardiac tumor.
  • [MeSH-major] Heart Neoplasms / secondary. Heart Neoplasms / surgery
  • [MeSH-minor] Angiography. Chemotherapy, Adjuvant. Combined Modality Therapy. Diagnosis, Differential. Echocardiography. Humans. Magnetic Resonance Imaging. Myocardium / pathology. Myxoma / diagnosis. Myxoma / pathology. Myxoma / surgery. Prognosis. Radiotherapy, Adjuvant. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010. Published by Elsevier Masson SAS.
  • (PMID = 20207301.001).
  • [ISSN] 0761-8417
  • [Journal-full-title] Revue de pneumologie clinique
  • [ISO-abbreviation] Rev Pneumol Clin
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 28
  •  go-up   go-down


22. Centella T, Oliva E, García Andrade I, Lamas MJ, Epeldegui A: [A patient with cardiac angiosarcoma who survived for four years. Case report and literature review]. Rev Esp Cardiol; 2005 Mar;58(3):310-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A patient with cardiac angiosarcoma who survived for four years. Case report and literature review].
  • We describe a 57-year-old woman with a diagnosis of primary cardiac angiosarcoma.
  • She underwent emergency surgery with a preoperative diagnosis of atrial myxoma, and pathological analysis confirmed the diagnosis of cardiac angiosarcoma.
  • The mortality associated with primary cardiac neoplasm is very high, although aggressive treatment together with appropriate chemotherapy may significantly prolong patient's lifespan.
  • [MeSH-major] Heart Neoplasms. Hemangiosarcoma
  • [MeSH-minor] Female. Humans. Middle Aged. Survivors. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15766456.001).
  • [ISSN] 0300-8932
  • [Journal-full-title] Revista española de cardiología
  • [ISO-abbreviation] Rev Esp Cardiol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 5
  •  go-up   go-down


23. Hoppe UC: [Cardiac disease in patients with tumors and tumor therapy]. Med Klin (Munich); 2006 Mar 22;101 Suppl 1:31-5
MedlinePlus Health Information. consumer health - Cardiomyopathy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cardiac disease in patients with tumors and tumor therapy].
  • Cardiac disease may occur as direct complications of heart tumors or indirect complications of malignancies related to antineoplastic therapy.
  • While primary cardiac neoplasias are rare, metastases to various cardiac structures are common.
  • Cardiac tumors may cause a wide variety of clinical signs and symptoms.
  • Nearly all primary cardiac malignancies are sarcomas with a poor prognosis.
  • Cancer treatment, most frequently anthracyclines, but also trastuzumab, cyclophosphamide and others may compromise cardiac function.
  • The severity of such toxicity depends on many factors such as the molecular site of action, the immediate and cumulative dose, the method of administration, the presence of any underlying cardiac condition, and the patient's demographics.
  • Moreover, toxicity can be affected by current or previous treatment with other antineoplastic agents or by concomitant irrradiation.
  • Cardiotoxic effects can occur immediately during administration of the drug, or they may not manifest themselves until months or years after the patient has been treated.
  • Radiation ports that include the heart may produce late coronary artery disease or constrictive pericarditis.
  • Since cardiovascular disease and cancer are both common, precise knowledge of therapeutic interactions and complications is warranted.
  • [MeSH-major] Antineoplastic Agents / adverse effects. Cardiomyopathies / chemically induced. Heart / radiation effects. Heart Neoplasms / secondary. Myxoma / diagnosis. Neoplasms / diagnosis. Radiation Injuries / diagnosis
  • [MeSH-minor] Combined Modality Therapy / adverse effects. Hemodynamics / drug effects. Hemodynamics / radiation effects. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16802515.001).
  • [ISSN] 0723-5003
  • [Journal-full-title] Medizinische Klinik (Munich, Germany : 1983)
  • [ISO-abbreviation] Med. Klin. (Munich)
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


24. Gaudio C, Di Michele S, Cera M, Nguyen BL, Pannarale G, Alessandri N: Prominent crista terminalis mimicking a right atrial mixoma: cardiac magnetic resonance aspects. Eur Rev Med Pharmacol Sci; 2004 Jul-Aug;8(4):165-8
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prominent crista terminalis mimicking a right atrial mixoma: cardiac magnetic resonance aspects.
  • The ECG showed sinus rhythm with heart rate of 68 beats per minute and signs of left ventricular hypertrophy without strain.
  • Further investigation included an echocardiogram that showed normal left and right cavities and normal cardiac valves.
  • At the level of the posterior wall of the right atrial (RA) an apparent smooth, bean-like tumor, having a thin pedicle, was identified as a RA mixoma.
  • Cardiac MRI was requested and showed in two sequential slices a muscular ridge, identified as a prominent crista terminalis.
  • The multiplain projections of MRI allow the cardiologist to identify the presence of intracardiac masses and to make a differential diagnosis between neoplasms and variant anatomic structures.
  • [MeSH-major] Heart / anatomy & histology. Heart Neoplasms / diagnosis. Magnetic Resonance Imaging. Myxoma / diagnosis
  • [MeSH-minor] Aged. Antihypertensive Agents / therapeutic use. Diagnosis, Differential. Echocardiography. Female. Heart Atria / anatomy & histology. Humans. Hypertension / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15636402.001).
  • [ISSN] 1128-3602
  • [Journal-full-title] European review for medical and pharmacological sciences
  • [ISO-abbreviation] Eur Rev Med Pharmacol Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antihypertensive Agents
  •  go-up   go-down


25. Piper SN, Werner U, Maleck WH, Schmidt CC, Saggau W, Munderloh KH, Boldt J: Recurrent atrial sarcoma presenting as an atrial myxoma. Long-term survival due to surgical intervention and chemotherapy. J Cardiovasc Surg (Torino); 2000 Dec;41(6):961-4
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent atrial sarcoma presenting as an atrial myxoma. Long-term survival due to surgical intervention and chemotherapy.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cardiac Surgical Procedures. Heart Atria. Heart Neoplasms / therapy. Myxoma / diagnosis. Neoplasm Recurrence, Local. Sarcoma / therapy
  • [MeSH-minor] Adult. Diagnosis, Differential. Echocardiography. Follow-Up Studies. Humans. Male. Prognosis

  • MedlinePlus Health Information. consumer health - Heart Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11232985.001).
  • [ISSN] 0021-9509
  • [Journal-full-title] The Journal of cardiovascular surgery
  • [ISO-abbreviation] J Cardiovasc Surg (Torino)
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Italy
  •  go-up   go-down


26. Steward MJ, D'Cruz DP, Lang-Lazdunski L, Chambers J: Fever, haemoptysis and a mass in the heart. J R Soc Med; 2007 Feb;100(2):105-6
Hazardous Substances Data Bank. WARFARIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fever, haemoptysis and a mass in the heart.
  • [MeSH-major] Antiphospholipid Syndrome / diagnosis. Behcet Syndrome / diagnosis
  • [MeSH-minor] Adult. Anticoagulants / therapeutic use. Diagnosis, Differential. Fever / diagnosis. Fever / drug therapy. Humans. Male. Myxoma / diagnosis. Tomography, X-Ray Computed. Treatment Outcome. Warfarin / therapeutic use

  • MedlinePlus Health Information. consumer health - Behcet's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Rheumatol. 1994 Jan;33(1):48-51 [8162457.001]
  • [Cites] J Vasc Interv Radiol. 1999 May;10(5):649-52 [10357493.001]
  • [Cites] Int J Cardiol. 1997 May 23;59(3):267-73 [9183042.001]
  • [Cites] Lancet. 1990 May 5;335(8697):1078-80 [1970380.001]
  • [Cites] Ann Rheum Dis. 1984 Oct;43(5):746-8 [6497467.001]
  • [Cites] J Dermatol. 1990 Mar;17(3):164-7 [2355142.001]
  • (PMID = 17277285.001).
  • [ISSN] 0141-0768
  • [Journal-full-title] Journal of the Royal Society of Medicine
  • [ISO-abbreviation] J R Soc Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anticoagulants; 5Q7ZVV76EI / Warfarin
  • [Other-IDs] NLM/ PMC1790978
  •  go-up   go-down


27. Hesse B, Murphy RT, Myles J, Huang J, Sabik EM: Images in cardiovascular medicine. A left atrial appendage thrombus mimicking atrial myxoma. Circulation; 2006 Mar 21;113(11):e456-7
Hazardous Substances Data Bank. WARFARIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Images in cardiovascular medicine. A left atrial appendage thrombus mimicking atrial myxoma.
  • [MeSH-major] Atrial Appendage. Echocardiography, Doppler, Pulsed. Echocardiography, Transesophageal. Heart Diseases / ultrasonography. Heart Neoplasms / diagnosis. Myxoma / diagnosis. Thrombosis / ultrasonography
  • [MeSH-minor] Anticoagulants / therapeutic use. Atrial Fibrillation / complications. Atrial Fibrillation / drug therapy. Diagnosis, Differential. Female. Humans. Hypertension / etiology. Middle Aged. Warfarin / therapeutic use

  • MedlinePlus Health Information. consumer health - Blood Clots.
  • MedlinePlus Health Information. consumer health - Heart Disease in Women.
  • MedlinePlus Health Information. consumer health - Heart Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16549642.001).
  • [ISSN] 1524-4539
  • [Journal-full-title] Circulation
  • [ISO-abbreviation] Circulation
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 5Q7ZVV76EI / Warfarin
  •  go-up   go-down






Advertisement